Skip to content

SG&A at other companies

Stryker logo
StrykerSYK
$2.28B-0.8%
Coherent logo
CoherentCOHR
$267.64M+15.6%
Intuitive Surgical logo
Intuitive SurgicalISRG
$613.3M+8.9%
Nordson logo
NordsonNDSN
$206.87M+0.8%
Belden logo
BeldenBDC
$138.65M+5.4%
ROP
Roper Technologies, Inc.ROP
$884.2M+15.1%

Segments

By segment

See full
Automation Enabling Technologies$19.89M+3.8%
Medical Solutions$16.31M+10.7%

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's SG&A?
Novanta (NOVT) reported SG&A of $54.41M in Q1 2026.
How has Novanta's SG&A changed year-over-year?
Novanta's SG&A increased by 19.3% year-over-year, from $45.6M to $54.41M.
What is the long-term trend for Novanta's SG&A?
Over 4 years (2021 to 2025), Novanta's SG&A has grown at a 10.9% compound annual growth rate (CAGR), from $129.16M to $195.66M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.